Westlake Chemical Partners LP Announces Second Quarter 2025 Distribution
Get Alerts WLKP Hot Sheet
Join SI Premium – FREE
- $0.4714 per unit distribution declared payable on August 27, 2025
HOUSTON--(BUSINESS WIRE)-- The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE: WLKP), has declared a distribution of $0.4714 per unit. This is the 44th quarterly distribution announced by the Partnership since its initial public offering. The distribution will be payable on August 27, 2025, to unit holders of record on August 12, 2025.
This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (100.0%) of the Partnership’s distributions to non-U.S. investors as being attributable to income that is effectively connected with a United States trade or business. Accordingly, the Partnership’s distributions to non-U.S. investors are subject to federal income tax withholding at the highest applicable effective tax rate.
About Westlake Chemical Partners LP
Westlake Chemical Partners is a limited partnership formed by Westlake Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns a 22.8% interest in Westlake Chemical OpCo LP. Westlake Chemical OpCo LP’s assets include three facilities in Calvert City, Kentucky, and Lake Charles, Louisiana which process ethane and propane into ethylene, and an ethylene pipeline. For more information about Westlake Chemical Partners LP, please visit http://www.wlkpartners.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250723285501/en/
Media Inquiries:
Westlake Corp.
Ben Ederington, 1-713-585-2900
or
Investor Inquiries:
Westlake Corp.
Steve Bender, 1-713-585-2900
Source: Westlake Chemical Partners
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026
- Parksy (parksy.com) Mapped Parking Around 12 of America's Biggest Venues: Nearly 2,000 Options Near Madison Square Garden, 18 Near Hard Rock Stadium
- Crypto Regulation Watch: New SEC Proposal Reshapes the Backdrop for September Presales as VOIDTRACE AI Prepares $VOIDE
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Definitive Agreement, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share